The Journal of Pediatrics
Volume 150, Issue 6 , Pages 627-630 , June 2007

Assessment of Tetrahydrobiopterin (BH4) Responsiveness in Phenylketonuria

  • Betina Fiege, MD

      Affiliations

    • Division of Metabolism and Molecular Pediatrics, University Children’s Hospital, Zurich, Switzerland.
    • ,
  • Nenad Blau, PhD

      Affiliations

    • Division of Clinical Chemistry and Biochemistry, University Children’s Hospital, Zurich, Switzerland.
    • Corresponding Author InformationReprint requests: Dr Nenad Blau, Division of Clinical Chemistry and Biochemistry, University Children’s Hospital, Steinwiesstrasse 75, 8032 Zurich, Switzerland.

Received 27 October 2006 ,Revised 9 January 2007 ,Accepted 1 February 2007.

References 

  1. Scriver CR, Kaufman S. Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In:  Scriver CR,  Beaudet AL,  Sly WS,  Valle D,  Childs B,  Vogelstein B editor. The Metabolic and Molecular Bases of Inherited Disease. 8th edition. New York: McGraw-Hill; 2001;p. 1667–1724
  2. Walter JH, White FJ, Hall SK, MacDonald A, Rylance G, Boneh A, et al. How practical are recommendations for dietary control in phenylketonuria?. Lancet. 2002;360:55–57
  3. Brown AS, Fernhoff PM, Waisbren SE, Frazier DM, Singh R, Rohr F, et al. Barriers to successful dietary control among pregnant women with phenylketonuria. Genet Med. 2002;4:84–89
  4. Kure S, Hou DC, Ohura T, Iwamoto H, Suzuki S, Sugiyama N, et al. Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. J Pediatr. 1999;135:375–378
  5. Bernegger C, Blau N. High frequency of tetrahydrobiopterin responsiveness among hyperphenylalaninemias: a study of 1919 patients observed from 1988 to 2002. Mol Genet Metab. 2002;77:304–313
  6. Lässker U, Zschocke J, Blau N, Santer R. Tetrahydrobiopterin responsiveness in phenylketonuria: two new cases and a review of molecular genetic findings. J Inherit Metab Dis. 2002;25:65–70
  7. Shintaku H, Kure S, Ohura T, Okano Y, Ohwada M, Sugiyama N, et al. Long-term treatment and diagnosis of tetrahydrobiopterin-responsive hyperphenylalaninemia with a mutant phenylalanine hydroxylase gene. Pediatr Res. 2004;55:425–430
  8. Matalon R, Koch R, Michals-Matalon K, Moseley K, Surendran S, Tyring S, et al. Biopterin-responsive phenylalanine hydroxylase deficiency. Genet Med. 2004;6:27–32
  9. Spaapen LJM, Bakker JA, Velter C, Loots W, Rubio ME, Forget PP, et al. Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency in Dutch neonates. J Inherit Metab Dis. 2001;24:325–358
  10. Lindner M, Steinfeld R, Burgard P, Schulze A, Mayatepek E, Zschocke J. Tetrahydrobiopterin sensitivity in German patients with mild phenylalanine hydroxylase deficiency. Hum Mutat. 2003;21:400
  11. Lücke T, Illsinger S, Aulehla-Scholz C, Sander J, Das AM. BH4-sensitive hyperphenylalaninemia: new case and review of literature. Pediatr Neurol. 2003;28:228–230
  12. Steinfeld R, Kohlschutter A, Ullrich K, Lukacs Z. A hypothesis on the biochemical mechanism of BH(4) responsiveness in phenylalanine hydroxylase deficiency. Amino Acids. 2003;25:63–68
  13. Desviat LR, Pérez B, Bèlanger-Quintana A, Castro M, Aguado C, Sánchez A, et al. Tetrahydrobiopterin responsiveness: results of the BH4-loading test in 31 Spanish PKU patients and correlation with their genotype. Mol Genet Metab. 2004;82:157–162
  14. Fiori L, Fiege B, Riva E, Giovannini M. Incidence of BH4-responsiveness in phenylalanine hydroxylase–deficient Italian patients. Mol Genet Metab. 2005;86:67–74
  15. Leuzzi V, Carducci C, Chiarotti F, Artiola C, Giovanniello T, et al. The spectrum of phenylalanine variations under tetrahydrobiopterin load in subjects affected by phenylalanine hydroxylase deficiency. J Inherit Metab Dis. 2006;29:38–46
  16. Muntau AC, Roschinger W, Habich M, Demmelmair H, Hoffmann B, Sommerhoff CP, et al. Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria. N Engl J Med. 2002;347:2122–2132
  17. Perez-Duenas B, Vilaseca MA, Mas A, Lambruschini N, Artuch R, Gomez L, et al. Tetrahydrobiopterin responsiveness in patients with phenylketonuria. Clin Biochem. 2004;37:1083–1090
  18. Okano Y, Hase Y, Kawajiri M, Nishi Y, Inui K, Sakai N, et al. In vivo studies of phenylalanine hydroxylase by phenylalanine breath test: diagnosis of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. Pediatr Res. 2004;56:714–719
  19. Mitchell JJ, Wilcken B, Alexander I, Ellaway C, O’Grady H, Wiley V, et al. Tetrahydrobiopterin-responsive phenylketonuria: the New South Wales experience. Mol Genet Metab. 2005;86:81–85
  20. Trefz FK, Scheible D, Frauendienst-Egger G, Korall H, Blau N. Long-term treatment of patients with mild and classical phenylketonuria by tetrahydrobiopterin. Mol Genet Metab. 2005;86:75–80
  21. Hennermann JB, Bührer C, Blau N, Vetter B, Mönch E. Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in classic and mild phenylketonuria. Mol Genet Metab. 2005;86:86–90
  22. Steinfeld R, Kohlschütter A, Ullrich K, Lukacs L. Efficiency of long-term tetrahydrobiopterin monotherapy in phenylketonuria. J Inherit Metab Dis. 2004;27:449–453
  23. Cerone R, Schiaffino MC, Fantasia AR, Perfumo M, Birk Moller L, Blau N. Long-term follow-up of a patient with mild tetrahydrobiopterin-responsive phenylketonuria. Mol Genet Metab. 2004;81:137–139
  24. Lambruschini N, Perez-Duenas B, Vilaseca MA, Mas A, Artuch R, Gassio R, et al. Clinical and nutritional evaluation of phenylketonuric patients on tetrahydrobiopterin monotherapy. Mol Genet Metab. 2005;86:54–60
  25. Belanger-Quintana A, Garcia MJ, Castro M, Desviat LR, Perez B, Mejia B, et al. Spanish BH4-responsive phenylalanine hydroxylase-deficient patients: evolution of seven patients on long-term treatment with tetrahydrobiopterin. Mol Genet Metab. 2005;86:61–66
  26. Blau N, Erlandsen H. The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. Mol Genet Metab. 2004;82:101–111
  27. Lindner M. Treatment of phenylketonuria variants: European recommendations. In:  Blau N editors. PKU and BH4: Advances in Phenylketonuria and Tetrahydrobiopterin. Heilbronn, Germany: SPS Verlagsgesellschaft mbH; 2006;p. 180–187
  28. Matalon R, Michals-Matalon K. Treatment of phenylketonuria variants: US recommendations. In:  Blau N editors. PKU and BH4: Advances in Phenylketonuria and Tetrahydrobiopterin. Heilbronn, Germany: SPS Verlagsgesellschaft mbH; 2006;p. 201–219
  29. Blau N, Muntau A. Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. EMG Workshop Results. Friedrichsdorf: Milupa; 2002;
  30. Spaapen LJ, Estela Rubio-Gozalbo M. Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency: state of the art. Mol Genet Metab. 2003;78:93–99
  31. Fiege B, Bonafé L, Ballhausen D, Baumgartner M, Thöny B, Meili D, et al. Extended tetrahydrobiopterin-loading test in the diagnosis of cofactor-responsive phenylketonuria: a pilot study. Mol Genet Metab. 2005;86:91–95
  32. Weglage J, Grenzebach M, von Teeffelen-Heithoff A, Marquardt T, Feldmann R, Denecke J, et al. Tetrahydrobiopterin responsiveness in a large series of phenylketonuria patients. J Inherit Metab Dis. 2002;25:321–322
  33. Pey AL, Martinez A. The activity of wild-type and mutant phenylalanine hydroxylase and its regulation by phenylalanine and tetrahydrobiopterin at physiological and pathological concentrations: an isothermal titration calorimetry study. Mol Genet Metab. 2005;86:43–53
  34. Fiege B, Ballhausen D, Kierat L, Leimbacher W, Goriouniv D, Schircks B, et al. Plasma tetrahydrobiopterin and its pharmacokinetics following oral administration. Mol Genet Metab. 2004;81:45–51
  35. Zurflüh MR, Fiori L, Fiege B, Kuru NB, Demirkol M, Gärtner KH, et al. Pharmacokinetics of orally administered tetrahydrobiopterin in patients with phenylalanine hydroxylase deficiency. J Inherit Metab Dis. 2006;29:725–731

 Supported by the Swiss National Science Foundation (grant 3100000-107500/1).

PII: S0022-3476(07)00137-0

doi: 10.1016/j.jpeds.2007.02.017

The Journal of Pediatrics
Volume 150, Issue 6 , Pages 627-630 , June 2007

Article Tools

* Image Usage & Resolution